Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vesicle-associated membrane protein 5 (VAMP5) is a member of the SNARE superfamily, specifically the VAMP/synaptobrevin protein family, which is essential for vesicular fusion and membrane trafficking[1][2][3][4][5]. VAMP5 is predominantly expressed in skeletal muscle and heart, with key roles in vesicle trafficking during myogenesis and in phagosome formation within macrophages, interacting with other SNAREs such as SNAP23[2][3][5]. Genetic studies have implicated VAMP5 variants as risk factors for Hirschsprung disease, reflecting its importance in vesicle transport for neural crest cell function[1]. VAMP5 has also been studied for potential contributions to tumor progression and investigated as a candidate in other diseases, though direct therapeutic targeting and interacting drugs have not been established[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicle-associated membrane protein 5 (VAMP5).